1Burmester GR, Stulmuller B, keyszer G, et al. Mononuclear phagocytes and rheumatoid arthitis, mastermind er workhorse in arthritis.? Arthritis Rheum, 1997,40 ( 1 ): 5 ～ 18.
2William PA. The pathophysiology and treatment of rheumatoid arthritis. Arthritis Rheum, 1997,40(4) :595 ～ 597.
3Edwands SW, Hallett MB. Seeing the wood for the trees: the forgotten role of neutrophils in rheumatoid arthritis. Immunol Today, 1997,18 (7) :320 ～ 324.
4Franz, JK, Pap T, Hummel,KM,et al. Expression of sentrin, a novel antiapoptotic molecule, at sites of synovial invasion in rheumatoid arthritis. Arthritis Rheum, 2000,43(3) :569 ～ 607.
5Moore KW, O Gara A, De waal Malefyt R, et al. Interleukin-10. Annu Rev Immunal, 1993,11 (2): 165 - 190.
6Kuga S,Otsuka T, Niiro H, et al. Suppression of superoxide anion production by interleukin10 is accompanied by a downregulation of the genes for sudunit proteins of NADPH oxidase. Exp Hematol, 1996,24(2): 151 ～ 157.
7Edwrd K, Janice W, Paul G, et al. The role of IL-10 in rbeumatoid arthritis. Rheu Dis Clin North Am, 1998,24(3) :629 - 639.
8Niiro H,Otsuka T,Izuhara K,et al. Regulation by interleukin-10 and interleukin-4 of cyclooxygenase-2 expression in human neutrophils. Blood, 1997, 89(5): 1621 ～ 1628.
9Niiro H, Otsuka T, Tanabe T, et al. Inhibition by interleukin-10 of inducible cyclooxygenase expression in ipoplysaccharide-stimulated monocytes: Its underlying mechanism in comparison with interleukin-4. Blood, 1995, 85(12) :3736 ～ 3745.
10Szekanca Z, Koch AE, Kunkel SL, et al. Cytokine in rheumatoid arthritis potential targets for pharmacological intervention. J Drugs Aging, 1998,12(3) :337 ～ 387.
